• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗 COVID-19 疫情估计研究的快速综述。

Rapid review of COVID-19 epidemic estimation studies for Iran.

机构信息

University of British Columbia, Vancouver, Canada.

Aberdeen Centre for Health Data Sciences, University of Aberdeen, Aberdeen, UK.

出版信息

BMC Public Health. 2021 Feb 1;21(1):257. doi: 10.1186/s12889-021-10183-3.

DOI:10.1186/s12889-021-10183-3
PMID:33522928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7848865/
Abstract

BACKGROUND

To inform researchers about the methodology and results of epidemic estimation studies performed for COVID-19 epidemic in Iran, we aimed to perform a rapid review.

METHODS

We searched for and included published articles, preprint manuscripts and reports that estimated numbers of cumulative or daily deaths or cases of COVID-19 in Iran. We found 131 studies and included 29 of them.

RESULTS

The included studies provided outputs for a total of 84 study-model/scenario combinations. Sixteen studies used 3-4 compartmental disease models. At the end of month two of the epidemic (2020-04-19), the lowest (and highest) values of predictions were 1,777 (388,951) for cumulative deaths, 20,588 (2,310,161) for cumulative cases, and at the end of month four (2020-06-20), were 3,590 (1,819,392) for cumulative deaths, and 144,305 (4,266,964) for cumulative cases. Highest estimates of cumulative deaths (and cases) for latest date available in 2020 were 418,834 on 2020-12-19 (and 41,475,792 on 2020-12-31). Model estimates predict an ominous course of epidemic progress in Iran. Increase in percent population using masks from the current situation to 95% might prevent 26,790 additional deaths (95% confidence interval 19,925-35,208) by the end of year 2020.

CONCLUSIONS

Meticulousness and degree of details reported for disease modeling and statistical methods used in the included studies varied widely. Greater heterogeneity was observed regarding the results of predicted outcomes. Consideration of minimum and preferred reporting items in epidemic estimation studies might better inform future revisions of the available models and new models to be developed. Not accounting for under-reporting drives the models' results misleading.

摘要

背景

为了向研究人员介绍针对伊朗 COVID-19 疫情进行的疫情估计研究的方法和结果,我们旨在进行快速审查。

方法

我们搜索并纳入了已发表的文章、预印本手稿和报告,这些文章和报告估计了伊朗 COVID-19 的累计或每日死亡或病例数。我们共发现 131 项研究,纳入了其中的 29 项。

结果

纳入的研究共提供了 84 项研究模型/方案组合的结果。16 项研究使用了 3-4 compartmental 疾病模型。在疫情的第二个月月底(2020-04-19),预测的最低(和最高)累计死亡值为 1777(388951),累计病例数为 20588(2310161),在第四个月月底(2020-06-20),累计死亡数为 3590(1819392),累计病例数为 144305(4266964)。2020 年最新数据中,累计死亡人数(和病例数)的最高估计值为 2020 年 12 月 19 日的 418834 人(2020 年 12 月 31 日的 41475792 人)。模型预测显示,伊朗疫情的发展趋势不容乐观。如果目前的口罩使用率(95%)增加到 95%,则到 2020 年底可能会避免额外的 26790 人死亡(95%置信区间为 19925-35208)。

结论

纳入研究中疾病建模和统计方法的细致程度和详细程度差异很大。预测结果的异质性更大。在疫情估计研究中考虑最低和首选报告项目可能会更好地为现有模型的修订和新模型的开发提供信息。未考虑漏报会导致模型结果产生误导。

相似文献

1
Rapid review of COVID-19 epidemic estimation studies for Iran.伊朗 COVID-19 疫情估计研究的快速综述。
BMC Public Health. 2021 Feb 1;21(1):257. doi: 10.1186/s12889-021-10183-3.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Lessons for preparedness and reasons for concern from the early COVID-19 epidemic in Iran.从伊朗 COVID-19 疫情早期中吸取的准备教训和关注原因。
Epidemics. 2021 Sep;36:100472. doi: 10.1016/j.epidem.2021.100472. Epub 2021 May 29.
4
Effect of epidemic management and control plan on COVID-19 mortality in Iran: an interrupted time series analysis.伊朗疫情管理和控制方案对 COVID-19 死亡率的影响:一项中断时间序列分析。
J Prev Med Hyg. 2022 Apr 26;63(1):E125-E129. doi: 10.15167/2421-4248/jpmh2022.63.1.2337. eCollection 2022 Mar.
5
How Can the Epidemic Curve of COVID-19 in Iran Be Interpreted?如何解读伊朗新冠肺炎疫情曲线?
J Res Health Sci. 2020 Oct 4;20(3):e00491. doi: 10.34172/jrhs.2020.27.
6
Impact of Non-pharmaceutical Interventions on the Control of COVID-19 in Iran: A Mathematical Modeling Study.非药物干预对伊朗 COVID-19 控制的影响:一项数学建模研究。
Int J Health Policy Manag. 2022 Aug 1;11(8):1472-1481. doi: 10.34172/ijhpm.2021.48. Epub 2021 Jun 9.
7
Short-term real-time prediction of total number of reported COVID-19 cases and deaths in South Africa: a data driven approach.南非报告的 COVID-19 病例和死亡总数的短期实时预测:一种数据驱动的方法。
BMC Med Res Methodol. 2021 Jan 11;21(1):15. doi: 10.1186/s12874-020-01165-x.
8
Compartmental structures used in modeling COVID-19: a scoping review.用于建模 COVID-19 的隔室结构:范围综述。
Infect Dis Poverty. 2022 Jun 21;11(1):72. doi: 10.1186/s40249-022-01001-y.
9
Iran COVID-19 Epidemiology Committee: A Review of Missions, Structures, Achievements, and Challenges.伊朗新冠肺炎疫情流行病学委员会:任务、结构、成就及挑战综述
J Res Health Sci. 2021 Mar 7;21(1):e00505. doi: 10.34172/jrhs.2021.45.
10
Modeling and forecasting trend of COVID-19 epidemic in Iran until May 13, 2020.2020年5月13日前伊朗新冠肺炎疫情的建模与预测趋势
Med J Islam Repub Iran. 2020 Mar 31;34:27. doi: 10.34171/mjiri.34.27. eCollection 2020.

引用本文的文献

1
Association between COVID-19 Mortality and Underlying Disease; Tehran, Iran.伊朗德黑兰:新冠病毒疾病死亡率与基础疾病之间的关联
J Caring Sci. 2024 Jun 2;14(1):37-41. doi: 10.34172/jcs.025.33254. eCollection 2025 Feb.
2
Direct Inpatient Cost and Payments of COVID-19 in Iran: Quantile Regression Analysis.伊朗新冠肺炎患者的直接住院费用及支付情况:分位数回归分析
Med J Islam Repub Iran. 2022 Sep 3;36:101. doi: 10.47176/mjiri.36.101. eCollection 2022.
3
Immunophenotyping characteristics of COVID-19 patients: Peripheral blood CD8+ HLA-DR+ T cells as a biomarker for mortality outcome.

本文引用的文献

1
Infection fatality rate of COVID-19 inferred from seroprevalence data.基于血清流行率数据推断的 COVID-19 感染病死率。
Bull World Health Organ. 2021 Jan 1;99(1):19-33F. doi: 10.2471/BLT.20.265892. Epub 2020 Oct 14.
2
COVID-19 antibody seroprevalence in Santa Clara County, California.加利福尼亚州圣克拉拉县的新冠病毒抗体血清流行率。
Int J Epidemiol. 2021 May 17;50(2):410-419. doi: 10.1093/ije/dyab010.
3
All-cause excess mortality and COVID-19-related deaths in Iran.伊朗的全因超额死亡率和与新冠病毒相关的死亡情况。
新型冠状病毒肺炎患者的免疫表型特征:外周血 CD8+HLA-DR+T 细胞作为死亡率结局的生物标志物。
J Med Virol. 2023 Jan;95(1):e28192. doi: 10.1002/jmv.28192. Epub 2022 Oct 19.
4
Evaluating the characteristics of patients with SARS-CoV-2 infection admitted during COVID-19 peaks: A single-center study.评估新冠疫情高峰期收治的新型冠状病毒肺炎患者特征:一项单中心研究。
Vacunas. 2023 Jan-Mar;24(1):27-36. doi: 10.1016/j.vacun.2022.08.002. Epub 2022 Aug 30.
5
Can Free Living Act as a Trojan Horse for SARS-Cov-2 on Viral Survival and Transmission in the Environment? A Narrative Review.自由生活的环境因素会成为新冠病毒在环境中存活和传播的“特洛伊木马”吗?一篇综述。
Iran J Parasitol. 2022 Apr-Jun;17(2):138-144. doi: 10.18502/ijpa.v17i2.9529.
6
Are lipid ratios and triglyceride-glucose index associated with critical care outcomes in COVID-19 patients?脂联素比值和甘油三酯-葡萄糖指数与 COVID-19 患者的重症监护结局相关吗?
PLoS One. 2022 Aug 1;17(8):e0272000. doi: 10.1371/journal.pone.0272000. eCollection 2022.
7
A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19.抗2019冠状病毒病蛋白质亚基疫苗综述
Front Microbiol. 2022 Jul 14;13:927306. doi: 10.3389/fmicb.2022.927306. eCollection 2022.
8
Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study.伊朗城市人群中 SARS-CoV-2 抗体的血清阳性率:来自第二项大型基于人群的横断面研究的结果。
BMC Public Health. 2022 May 23;22(1):1031. doi: 10.1186/s12889-022-13464-7.
9
CovidVisualized: Visualized compilation of international updated models' estimates of COVID-19 pandemic at global and country levels.CovidVisualized:全球和国家层面上对 COVID-19 大流行的国际更新模型估计的可视化汇编。
BMC Res Notes. 2022 Apr 9;15(1):136. doi: 10.1186/s13104-022-06020-4.
10
Exploring the experiences of nurses and physicians infected with COVID-19.探索感染新冠病毒的护士和医生的经历。
J Educ Health Promot. 2022 Jan 31;11:35. doi: 10.4103/jehp.jehp_604_21. eCollection 2022.
Med J Islam Repub Iran. 2020 Jul 15;34:80. doi: 10.34171/mjiri.34.80. eCollection 2020.
4
Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications.评估 COVID-19 感染病死率的年龄特异性:系统评价、荟萃分析及公共政策意义。
Eur J Epidemiol. 2020 Dec;35(12):1123-1138. doi: 10.1007/s10654-020-00698-1. Epub 2020 Dec 8.
5
Pseudo-likelihood based logistic regression for estimating COVID-19 infection and case fatality rates by gender, race, and age in California.基于伪似然的逻辑回归估计加利福尼亚州按性别、种族和年龄划分的 COVID-19 感染率和病死率。
Epidemics. 2020 Dec;33:100418. doi: 10.1016/j.epidem.2020.100418. Epub 2020 Nov 9.
6
Modeling COVID-19 scenarios for the United States.美国的 COVID-19 情景建模。
Nat Med. 2021 Jan;27(1):94-105. doi: 10.1038/s41591-020-1132-9. Epub 2020 Oct 23.
7
First Cases of SARS-CoV-2 in Iran, 2020: Case Series Report.2020年伊朗首例新型冠状病毒肺炎病例:病例系列报告。
Iran J Public Health. 2020 Aug;49(8):1564-1568. doi: 10.18502/ijph.v49i8.3903.
8
Covid-19's known unknowns.新冠疫情的已知未知因素。
BMJ. 2020 Oct 19;371:m3979. doi: 10.1136/bmj.m3979.
9
Power-law population heterogeneity governs epidemic waves.幂律人口异质性控制着疫情波。
PLoS One. 2020 Oct 14;15(10):e0239678. doi: 10.1371/journal.pone.0239678. eCollection 2020.
10
If the Objective is Herd Immunity, on Whom Should it be Built?如果目标是群体免疫,那么它应建立在谁的基础之上?
Environ Resour Econ (Dordr). 2020;76(4):671-683. doi: 10.1007/s10640-020-00504-2. Epub 2020 Aug 11.